cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Sorrento Therapeutics Inc
117 own
105 watching
Current Price
$1.05
$0.01
(0.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
491.71M
52-Week High
52-Week High
3.6
52-Week Low
52-Week Low
0.736
Average Volume
Average Volume
6.66M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
38.46
iconMarket Capitalization491.71M
icon52-Week High3.6
icon52-Week Low0.736
iconAverage Volume6.66M
iconDividend Yield--
iconP/E Ratio38.46
What does the Sorrento Therapeutics Inc do?
Sorrento Therapeutics, Inc., a clinical stage biotechnology company, primarily engages in the discovery and development of therapies focused on oncology and the treatment of chronic cancer pain worldwide. It develops therapeutic products for the treatment of auto-immune, inflammatory, neurodegenerative, and infectious diseases. The company offers resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for the treatment of intractable pain at end-stage disease. Its preclinical human therapeutic antibodies include antibody drug conjugates, bispecific approaches, and T-Cell Receptor, as well as Chimeric Antigen Receptor-T Cell (CAR-T) for adoptive cellular immunotherapy for the treatment of solid and liquid tumors. It is also involved in the development of T-007, an anti-CD38 CAR-T cellular therapy for the treatment of multiple myeloma, as well as for additional potential indications, such as amyloidosis and graft-versus-host disease; and T-009, an anti-CD123 CAR-T cellular therapy for the treatment of acute myelogenous leukemia. The company has license and collaboration agreement with Les Laboratoires Servier for the development, manufacture, and commercialization of products using its human immuno-oncology anti-PD-1 mAb STI-A1110. Sorrento Therapeutics, Inc. was founded in 2006 and is based in San Diego, California.
Read More
How much money does Sorrento Therapeutics Inc make?
News & Events about Sorrento Therapeutics Inc.
Globe Newswire
3days ago
PALO ALTO, Calif., Feb. 04, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, Scilex), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain ...
Globe Newswire
4days ago
SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento) today distributed dividend confirmation statements to 146 brokerage firms regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company (Nasdaq: SCLX, Scilex...
Insider Monkey
5days ago
In this article, we discuss the 5 hot healthcare stocks to buy now. If you want to read about some more hot healthcare stocks to buy now, go directly to 10 Hot Healthcare Stocks To Buy Now. 5. Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Number of Hedge Fund Holders: 10 YTD Perf: 167.99% Avg Volume: ...
Globe Newswire
6days ago
PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc.(Nasdaq: SRNE, Sorrento) today posted a supplement to its previously issued Frequently Asked Questions document under the Investors section ...
Globe Newswire
9days ago
SAN DIEGO, Jan. 29, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc.(Nasdaq: SRNE, Sorrento) today posted a Frequently Asked Questions document under the Investors section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common ...
Frequently Asked Questions
Frequently Asked Questions
What is Sorrento Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Sorrento Therapeutics Inc shares?
plus_minus_icon
How can I buy Sorrento Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Sorrento Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Sorrento Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Sorrento Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Sorrento Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Sorrento Therapeutics Inc?
plus_minus_icon
What percentage is Sorrento Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Sorrento Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.05
$0.01
(0.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00